MAPT and Alzheimer disease: Many studies have shown the tau burden measured from the tau PET imaging is highly correlated with neurodegeneration in AD (La Joie et al., 2020) and also exhibited high accuracy in differentiating AD from normal subjects and patients of other neurodegenerative disorders (Ossenkoppele et al., 2018; Mueller et al., 2020).